Current strategies for diagnosis and treatment of Clostridium difficile-infection (literature review)

The incidence and mortality rate of C. difficile infection (CDI) has increased remarkably over the last 10-20 years. CDI is a leading cause of healthcare-associated infections and antibiotic-associated diarrhoea. Increasing incidence and severity of CDI may be related with frequent antibiotic use an...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: I. V. Nikolaeva, I. V. Shestakova, G. K. Murtazina
Formato: article
Lenguaje:RU
Publicado: Scientific Сentre for Family Health and Human Reproduction Problems 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/8d67caa2569e4b6f96edc299b5d9b79e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8d67caa2569e4b6f96edc299b5d9b79e
record_format dspace
spelling oai:doaj.org-article:8d67caa2569e4b6f96edc299b5d9b79e2021-11-23T06:14:39ZCurrent strategies for diagnosis and treatment of Clostridium difficile-infection (literature review)2541-94202587-959610.29413/ABS.2018-3.1.5https://doaj.org/article/8d67caa2569e4b6f96edc299b5d9b79e2018-02-01T00:00:00Zhttps://www.actabiomedica.ru/jour/article/view/534https://doaj.org/toc/2541-9420https://doaj.org/toc/2587-9596The incidence and mortality rate of C. difficile infection (CDI) has increased remarkably over the last 10-20 years. CDI is a leading cause of healthcare-associated infections and antibiotic-associated diarrhoea. Increasing incidence and severity of CDI may be related with frequent antibiotic use and the emergence of a hypervirulent C. difficile strain. The epidemic strain NAP1 / BI / ribotype 027 is more resistant to antibiotics and produces more toxins and causes outbreaks around the world with increasing mortality and severity. Recent reports have documented that C. difficile infections occur among patients without traditional risk factors and the incidence of community-acquired CDI has increased. The clinical presentation of CDI ranging from the asymptomatic carrier to pseudomembranous colitis and toxic megacolon. The rate of recurrent CDI is 20-30 %. Early surgical consultation should be considered in all patients with severe or fulminant CDI. The preferred method for diagnosis CDI is stool testing using enzyme immunoassay (EIA) screening to look for glutamate dehydrogenase (GDH) antigen and toxins A and B. Metronidazole and vancomycin are recommended antibiotics for the treatment of CDI. Novel approaches include fidaxomicin therapy, monoclonal antibodies, and fecal microbiota transplantation. Fecal microbiota transplantation has shown relevant efficacy to overcome C. difficile infection and reduce it.I. V. NikolaevaI. V. ShestakovaG. K. MurtazinaScientific Сentre for Family Health and Human Reproduction Problemsarticleclostridium difficileclostridium difficileantibiotic-associated diarrheapseudomembranous colitisScienceQRUActa Biomedica Scientifica, Vol 3, Iss 1, Pp 34-42 (2018)
institution DOAJ
collection DOAJ
language RU
topic clostridium difficile
clostridium difficile
antibiotic-associated diarrhea
pseudomembranous colitis
Science
Q
spellingShingle clostridium difficile
clostridium difficile
antibiotic-associated diarrhea
pseudomembranous colitis
Science
Q
I. V. Nikolaeva
I. V. Shestakova
G. K. Murtazina
Current strategies for diagnosis and treatment of Clostridium difficile-infection (literature review)
description The incidence and mortality rate of C. difficile infection (CDI) has increased remarkably over the last 10-20 years. CDI is a leading cause of healthcare-associated infections and antibiotic-associated diarrhoea. Increasing incidence and severity of CDI may be related with frequent antibiotic use and the emergence of a hypervirulent C. difficile strain. The epidemic strain NAP1 / BI / ribotype 027 is more resistant to antibiotics and produces more toxins and causes outbreaks around the world with increasing mortality and severity. Recent reports have documented that C. difficile infections occur among patients without traditional risk factors and the incidence of community-acquired CDI has increased. The clinical presentation of CDI ranging from the asymptomatic carrier to pseudomembranous colitis and toxic megacolon. The rate of recurrent CDI is 20-30 %. Early surgical consultation should be considered in all patients with severe or fulminant CDI. The preferred method for diagnosis CDI is stool testing using enzyme immunoassay (EIA) screening to look for glutamate dehydrogenase (GDH) antigen and toxins A and B. Metronidazole and vancomycin are recommended antibiotics for the treatment of CDI. Novel approaches include fidaxomicin therapy, monoclonal antibodies, and fecal microbiota transplantation. Fecal microbiota transplantation has shown relevant efficacy to overcome C. difficile infection and reduce it.
format article
author I. V. Nikolaeva
I. V. Shestakova
G. K. Murtazina
author_facet I. V. Nikolaeva
I. V. Shestakova
G. K. Murtazina
author_sort I. V. Nikolaeva
title Current strategies for diagnosis and treatment of Clostridium difficile-infection (literature review)
title_short Current strategies for diagnosis and treatment of Clostridium difficile-infection (literature review)
title_full Current strategies for diagnosis and treatment of Clostridium difficile-infection (literature review)
title_fullStr Current strategies for diagnosis and treatment of Clostridium difficile-infection (literature review)
title_full_unstemmed Current strategies for diagnosis and treatment of Clostridium difficile-infection (literature review)
title_sort current strategies for diagnosis and treatment of clostridium difficile-infection (literature review)
publisher Scientific Сentre for Family Health and Human Reproduction Problems
publishDate 2018
url https://doaj.org/article/8d67caa2569e4b6f96edc299b5d9b79e
work_keys_str_mv AT ivnikolaeva currentstrategiesfordiagnosisandtreatmentofclostridiumdifficileinfectionliteraturereview
AT ivshestakova currentstrategiesfordiagnosisandtreatmentofclostridiumdifficileinfectionliteraturereview
AT gkmurtazina currentstrategiesfordiagnosisandtreatmentofclostridiumdifficileinfectionliteraturereview
_version_ 1718417020893003776